Indiana attorney general accuses Eli Lilly of conspiring to raise insulin prices in new lawsuit

LOUISVILLE, Ky. (WDRB) -- Indiana's top attorney is suing a major drugmaker over insulin prices.

Attorney General Todd Rokita filed a lawsuit against Eli Lilly and Company, claiming the drugmaker has conspired to raise prices on insulin medications for those with diabetes.

The lawsuit was filed Dec. 31 in Lake County, Fox59 reported, citing court documents.

The suit comes after Rokita filed an insulin-related lawsuit against multiple other drug manufacturers and pharmacy benefit managers in March 2024, which is now in federal court.

The Eli Lilly lawsuit alleges the company used a drug distribution scheme to raise prices on insulin medications.

“Pharmaceutical companies should not take advantage of Hoosiers or any other American—this includes Lilly, regardless of its Indiana roots,” Rokita said in a news release. “For two years, I attempted to resolve this matter with them amicably and without litigation—an effort not required by the state and one not afforded to Lilly’s out-of-state competitors. Lilly, which maintains by far the largest market share for insulin, rejected this outreach and consumed two years of time."

Rokita said he intends to have Indiana added to ongoing multistate litigation.

In a statement, the drugmaker said it is proud of its strong record of insulin affordability solutions that have made a real impact for Hoosiers and all Americans.

To read the lawsuit, click here.

Body camera video shows LMPD shoot armed man after ShotSpotter call in Russell neighborhood

Questions linger after Louisville police release body cam video of Bardstown Road shooting

Man dies after running back into burning southern Indiana home to save family dog

Council member pushes to close Louisville lounge after 4 people shot, including 17-year-old